Spero Therapeutics (SPRO) Profit After Tax Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 18.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.42% |
| Dec 31, 2025 | 5.54% |
| Sep 30, 2025 | 14.17% |
| Jun 30, 2025 | 61.01% |
| Mar 31, 2025 | 24.97% |
| Dec 31, 2024 | 10.63% |
| Sep 30, 2024 | 8.77% |
| Jun 30, 2024 | 1.29% |
| Mar 31, 2024 | 13.28% |
| Dec 31, 2023 | 68.16% |
| Sep 30, 2023 | 44.71% |
| Jun 30, 2023 | 12.03% |
| Mar 31, 2023 | 17.07% |
| Dec 31, 2022 | 45.36% |
| Sep 30, 2022 | 12.98% |
| Jun 30, 2022 | -29.69% |
| Mar 31, 2022 | -86.36% |
| Dec 31, 2021 | -40.32% |
| Sep 30, 2021 | -29.12% |
| Jun 30, 2021 | -23.10% |
| Mar 31, 2021 | -22.20% |
| Dec 31, 2020 | -10.25% |
| Sep 30, 2020 | -24.37% |
| Jun 30, 2020 | -21.48% |
| Mar 31, 2020 | -58.18% |
| Dec 31, 2019 | -44.99% |
| Sep 30, 2019 | -41.03% |